AKT-AMPKα-mTOR-dependent HIF-1α Activation is a New Therapeutic Target for Cancer Treatment: A Novel Approach to Repositioning the Antidiabetic Drug Sitagliptin for the Management of Hepatocellular Carcinoma
Eslam E. Abd El-Fattah(Delta University for Science and Technology)
Cited by 27
Related Papers
No related papers found
Powered by citation graph analysis